Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1977 Aug;32(4):424-8.
doi: 10.1136/thx.32.4.424.

Interaction between isoprenaline and aminophylline in asthma

Clinical Trial

Interaction between isoprenaline and aminophylline in asthma

I A Campbell et al. Thorax. 1977 Aug.

Abstract

Campbell, I. A., Middleton, W. G., McHardy, G. J. R., Shotter, Margaret V., McKenzie, R., and Kay, A. B. (1977).Thorax, 32, 424-428. Interaction between isoprenaline and aminophylline in asthma. Using a factorially designed study, 38 patients with bronchial asthma received a single dose of either isoprenaline by inhalation (9), aminophylline intravenously (10), isoprenaline and aminophylline (11), or placebo (8). The maximum expiratory flow (V max), the maximum expiratory flow at 50% of vital capacity (V max50), and the concentrations of plasma cyclic AMP were measured at time intervals up to two hours. The combination of isoprenaline and aminophylline acted synergistically in terms of the percent increase in V max50. However, this was statistically significant only at 20 minutes. Plasma cyclic AMP concentration rose with a similar time course of response to the changes in small airways. The elevations in plasma cyclic AMP observed with the drug combination were higher than those for the individual drugs at 10, 20, 30, and 60 minutes but these differences were not statistically significant. These observations support the concept that changes in bronchial smooth muscle tone are mediated by concentrations of cyclic nucleotides and that combinations of isoprenaline and aminophylline, rather than the administration of each drug separately, may have therapeutic advantages in the treatment of bronchial asthma.

PubMed Disclaimer

References

    1. J Pharmacol Exp Ther. 1963 Mar;139:269-74 - PubMed
    1. J Biol Chem. 1962 Apr;237:1244-50 - PubMed
    1. Q J Med. 1961 Apr;30:189-99 - PubMed
    1. Pharmacol Rev. 1956 Sep;8(3):339-87 - PubMed
    1. J Appl Physiol. 1953 Mar;5(9):508-12 - PubMed

Publication types

LinkOut - more resources